PriceTargets.com logo

GE HealthCare Technologies - GEHC Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $92.40
  • Forecasted Upside: 19.84%
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$77.10 As of 06/9/2023 01:00 AM ET
▼ -0.65 (-0.84%)

This chart shows the closing price for GEHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New GE HealthCare Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GEHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GEHC

Analyst Price Target is $92.40
▲ +19.84% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for GE HealthCare Technologies in the last 3 months. The average price target is $92.40, with a high forecast of $97.00 and a low forecast of $86.00. The average price target represents a 19.84% upside from the last price of $77.10.

This chart shows the closing price for GEHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 contributing investment analysts is to buy stock in GE HealthCare Technologies. This rating has held steady since January 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/16/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/14/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/11/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/11/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/10/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/9/2023

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2023OppenheimerInitiated CoverageOutperform$97.00Low
4/26/2023MizuhoBoost Target$92.00 ➝ $94.00Low
4/26/2023UBS GroupInitiated CoverageNeutral$86.00Low
4/19/2023Piper SandlerInitiated CoverageOverweight$95.00Low
4/18/2023MizuhoBoost Target$90.00 ➝ $92.00Low
4/10/2023BTIG ResearchInitiated CoverageNeutralLow
3/13/2023Evercore ISIInitiated CoverageOutperform$90.00Low
2/17/2023MizuhoInitiated CoverageBuy$90.00Low
1/19/2023Redburn PartnersInitiated CoverageBuyLow
1/4/2023Edward JonesInitiated CoverageHoldLow
(Data available from 6/9/2018 forward)

News Sentiment Rating

0.63 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/11/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/11/2022
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/10/2023
  • 4 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/9/2023
  • 5 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/11/2023
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/10/2023
  • 6 very positive mentions
  • 35 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/10/2023
  • 9 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/9/2023

Current Sentiment

  • 9 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

GE HealthCare Technologies logo
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is based in Chicago, Illinois.
Read More

Today's Range

Now: $77.10
Low: $77.06
High: $78.50

50 Day Range

MA: $80.16
Low: $74.92
High: $87.79

52 Week Range

Now: $77.10
Low: $53.00
High: $87.83

Volume

4,893,186 shs

Average Volume

3,077,940 shs

Market Capitalization

$35.06 billion

P/E Ratio

N/A

Dividend Yield

0.15%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of GE HealthCare Technologies?

The following Wall Street sell-side analysts have issued reports on GE HealthCare Technologies in the last twelve months: BTIG Research, Edward Jones, Evercore ISI, Mizuho, Oppenheimer Holdings Inc., Piper Sandler, Redburn Partners, and UBS Group AG.
View the latest analyst ratings for GEHC.

What is the current price target for GE HealthCare Technologies?

5 Wall Street analysts have set twelve-month price targets for GE HealthCare Technologies in the last year. Their average twelve-month price target is $92.40, suggesting a possible upside of 19.8%. Oppenheimer Holdings Inc. has the highest price target set, predicting GEHC will reach $97.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $86.00 for GE HealthCare Technologies in the next year.
View the latest price targets for GEHC.

What is the current consensus analyst rating for GE HealthCare Technologies?

GE HealthCare Technologies currently has 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GEHC will outperform the market and that investors should add to their positions of GE HealthCare Technologies.
View the latest ratings for GEHC.

What other companies compete with GE HealthCare Technologies?

Other companies that are similar to GE HealthCare Technologies include Hologic, Koninklijke Philips, Seagen, Centene and AmerisourceBergen. Learn More about companies similar to GE HealthCare Technologies.

How do I contact GE HealthCare Technologies' investor relations team?

The company's listed phone number is 617-443-3400 and its investor relations email address is [email protected]. The official website for GE HealthCare Technologies is www.gehealthcare.com. Learn More about contacing GE HealthCare Technologies investor relations.